Viral vectors for use in the development of biodefense vaccines
| Autor: | John S. Lee, Angela G. Hadjipanayis, Michael D. Parker |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Biodefense
viruses Pharmaceutical Science Viral Vaccines Biology medicine.disease_cause Virology Virus Viral vector chemistry.chemical_compound chemistry Pharmaceutical technology Virus Diseases Biological Warfare Biological warfare Venezuelan equine encephalitis virus Vaccines DNA medicine Animals Humans Vaccinia Biowarfare Agents |
| Zdroj: | Advanced Drug Delivery Reviews. 57:1293-1314 |
| ISSN: | 0169-409X |
| DOI: | 10.1016/j.addr.2005.01.011 |
| Popis: | The heightened concerns about bioterrorism and the use of biowarfare agents have prompted substantial increased efforts towards the development of vaccines against a wide range of organisms, toxins, and viruses. An increasing variety of platforms and strategies have been analyzed for their potential as vaccines against these agents. DNA vectors, live-attenuated viruses and bacteria, recombinant proteins combined with adjuvant, and viral- or bacterial-vectored vaccines have been developed as countermeasures against many potential agents of bioterrorism or biowarfare. The use of viruses, for example adenovirus, vaccinia virus, and Venezuelan equine encephalitis virus, as vaccine vectors has enabled researchers to develop effective means for countering the threat of bioterrorism and biowarfare. An overview of the different viral vectors and the threats they counter will be discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect